👀 I’m Just a Bill — Medicare Drug Price Negotiation Expansion

A Liana Banyan “I’m Just a Bill” Bounty Poster

What is this bill?

Expansion of Medicare’s drug-price negotiation authority (established in the 2022 IRA) in the 119th Congress. Current proposals expand the number of drugs subject to negotiation and accelerate the implementation timeline.

What does it actually do?

• Drug count: Increases the number of high-cost drugs CMS can negotiate annually
• Timeline: Accelerates eligibility-after-launch threshold
• Insulin/inhalers: Specific provisions for these drug classes
• Part B + Part D: Extends negotiation authority to Part B (physician-administered) drugs
• Penalties: Strengthens manufacturer-noncompliance penalties

Who votes when?

• Senate Finance + House Ways & Means + Energy & Commerce active consideration

How does this affect cooperative-class families?

Composes with #6 Tatiana Schlossberg Health Accords drug-pricing transparency, #7 MSA Substitution-routing economics, and the Affordable Insulin Now Act + Lower Costs More Transparency Act Bounty Posters.

Shirley Temple Truth Score

🟡 Provisional.

Help Each Other Help Ourselves.